Triple inactivated vaccine for Newcastle disease, infectious bronchitis, and avian influenza (H9 subtype) (LaSota strain, M41 strain, HZ strain). LaSota strain is preferred, combined with highly homologous strains of Newcastle disease circulating domestically; preferred infectious bronchitis strain provides excellent cross-protection for both respiratory and kidney types; preferred H9 subtype avian influenza HZ strain offers effective protection against currently circulating strains.

·       Carefully selected strains with high cross-protection
·       Antigen purification: ultrafiltration concentration process, effectively removing uric acid, endotoxins, and miscellaneous proteins from allantoic fluid
·       Imported adjuvant for better absorption: viscosity index of 20-40 cP (national standard 200 cP), promoting rapid antibody production
·       Advanced process with minimal immune stress: low-temperature emulsification and advanced inactivation process, using minimal formaldehyde inactivation
·       Concentrated antigen, good immune effect: significant antibody increase 7 days post-immunization

Usage and dosage: Subcutaneous injection in the neck. For chickens aged 14-35 days, 0.3 ml per bird; for chickens older than 35 days, 0.5 ml per bird.

Specification and packaging: 250 ml/bottle